FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

12 letters match. Newest first.

  1. NexCell Scientific Inc

    NexCell Scientific markets an unapproved, unlicensed umbilical cord blood cell product with serious manufacturing violations.

    High risk
  2. R3 Medical Companies

    FDA cites R3 Medical affiliates for selling unapproved umbilical cord and exosome biologics without licenses and with serious manufacturing violations.

    High risk
  3. Genzyme Ireland Limited

    CGMP/Deviations/Biologics License Application (BLA)

  4. Microvascular Tissue, Inc.

    CGMP/Deviations/Biologics License Application (BLA)

  5. Allovate Therapeutics, LLC

    CGMP/Deviations/Biologics License Application (BLA)

  6. New Life Medical Services, LLC

    CGMP/Deviations/Biologics License Application (BLA)

  7. MG Infusions

    CGMP/Deviations/Biologics License Application (BLA)

  8. Chara Biologics, Inc.

    CGMP/Deviations/Biologics License Application (BLA)

  9. Hemarus LLC

    CGMP/Blood & Blood Components/Adulterated

  10. Akan Biosciences, Inc.

    CGMP/Regulations for Human Cells, Tissues & Cellular Products (HCT/Ps)

  11. Human Microbes

    CGMP/Deviations/Biologics License Application (BLA)

  12. Fresenius Kabi AG

    CGMP Deviations